Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients ...
Stay updated with breaking news from Neurological Classification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients ...
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that the Company has submitted an...
In this systematic review with meta-analysis and meta-regression, Daniel D. Hodgkiss and colleagues investigate exercise and aerobic capacity in individuals with spinal cord injury.
Up-LIFT study achieves primary endpoint: Statistically significant and clinically meaningful improvement in upper extremity strength and functioni Improvement in arm and hand function is the highest
Press release content from Business Wire. The AP news staff was not involved in its creation.